...
首页> 外文期刊>Technology in cancer research & treatment. >Conformal Radiation Therapy or Stereotactic Body Radiation Therapy: Institutional Experience in the Management of Colorectal Liver Metastases by Radiation Therapy
【24h】

Conformal Radiation Therapy or Stereotactic Body Radiation Therapy: Institutional Experience in the Management of Colorectal Liver Metastases by Radiation Therapy

机译:保形放射疗法或立体定向体放射治疗:放射治疗中结直肠肝转移的制度经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aim: Radiation therapy has been proven “safe and effective” in the management of colorectal cancer liver metastases, especiallyfor oligometastases. However, to date, there is no consensus on optimal prescribed doses or dose fraction schemes. The currentstudy was conducted to investigate the effectiveness and safety of 2 different radiation therapy methods, conventional conformalradiation therapy and stereotactic body radiation therapy, in the treatment of limited colorectal cancer liver metastases.Methods: From December 2011 to December 2016, twenty-six patients with colorectal cancer having postoperative livermetastases (3) who were being treated with radiation therapy, either conventional conformal radiation therapy (50 Gy in 25fractions) or stereotactic body radiation therapy (50 Gy in 10 fractions), were selected for this study. Overall survival and localcontrol survival were analyzed by log-rank and Cox regression methods. Results: Radiation therapy delivered to each of the 26patients with a total of 50 liver lesions. Conformal radiation therapy was delivered to 32 lesions in a total of 15 patients. Stereotactic body radiation therapy was delivered to 18 lesions in a total of 11 patients. Median follow-up was 13 months. Three-yearoverall survival and local control survival were 0% and 38.5%, 20.5%, and 53.0%, respectively, for the conformal radiation therapyand stereotactic body radiation therapy groups. The slightly better overall survival and local control survival in the stereotacticbody radiation therapy group in comparison to the conformal radiation therapy group (P ? .323 and .297) is insignificant. Therewere no differences in grade 3 hepatic toxicity between the 2 groups. Eastern Cooperative Oncology Group performancestatus and the number of liver lesions were significant prognostic factors in both univariate and multivariate analyses.Conclusions: Noninvasive radiation therapy provides satisfactory survival benefit for limited colorectal cancer liver metastaseswithout intolerable toxicity and is therefore especially suitable for those elderly patients with poor performance status. Furthermore, stereotactic body radiation therapy with a higher biological equivalent dose and an abbreviated course of treatment hasbeen shown to provide a better outcome than conventional conformal radiation therapy.
机译:目的:在结直肠癌肝脏转移的管理中,放射治疗已被证明“安全有效”,尤其是脱寡馏分。然而,迄今为止,在最佳规定剂量或剂量分数方案上没有共识。进行了对象,以研究2种不同的放射治疗方法,常规的共形容度治疗和立体定向体辐射治疗的有效性和安全性,治疗有限结直肠癌肝脏转移。方法:从2011年12月到2016年12月,二十六名患者选择具有放射治疗的术后终素母孢菌酶(3)的结直肠癌,用于该研究选择常规保形放射治疗(50GY555.55.55.5°C 50 Gy)或静态体放射治疗(50Gy)。通过对数秩和COX回归方法分析总存活和局部控制存活。结果:辐射治疗送到26位,共有50例肝脏病变。共形放射疗法总共递送至32例病变,共15例。总体定向体放射疗法总共递送至18个病变,共11例。中位后续时间为13个月。对于保形放射治疗和立体定向体放射治疗组,三末期存活和局部对照存活分别为0%和38.5%,20.5%和53.0%。与全成形放射治疗组(P→.323和.297)相比,立体定向辐射治疗组中略微更好的整体存活和局部对照存活是微不足道的。 2组之间的3级肝毒性没有差异。东方合作肿瘤组织性能和肝脏病变的数量是单变量和多元局部分析的显着预后因素。结论:非侵袭性放射治疗为有限结直肠癌肝脏转移提供了令人满意的存活益处,这些疾病令人痛苦的毒性,因此特别适用于那些穷人的老年患者性能状态。此外,具有较高的生物等同剂量和缩写的治疗过程的立体定向体辐射治疗,显示出比常规保形放射疗法更好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号